ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

Brachytherapy Prevents Endometrial Cancer Return

June 27, 2008

NCAB To Hear Details Of New Grant Program, Hanna’s Frederick Plans

November 15, 1974

Clinical Trials: NCI Removes Brooklyn Site From PLCO Trials

October 24, 1997

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

September 15, 1978

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011